PHARMACIE LECOMTE
The computed 12-month bankruptcy probability of PHARMACIE LECOMTE is 0.4% (very low). The 2024 annual accounts show equity of €1.14M and a net result of €92k. Equity is growing by ~8.9% per year across the filed fiscal years. Its solvency ranks better than 95% of 866 sector peers (fiscal year 2024). The company has been active since 1993 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €1.14M |
| Net result | €92k |
| Staff (FTE) | 2 |
| Better than sector | 95% |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 83.6% | 17.3% | |
| Net result | €92k | €14k | |
| Equity | €1.14M | €100k | |
| Gross operating margin | €280k | €213k | |
| Staff costs | €139k | €219k |
| Fiscal year | 2024 |
|---|---|
| Deposit | volledig |
| Revenue | - |
| EBITDA | €135k |
| Net profit | €92k |
| Cash flow | €109k |
| Staff costs | €139k |
| Income taxes | €33k |
| Dividends | - |
| Total assets | €1.37M |
| Equity | €1.14M |
| Debt | €225k |
| of which ≤ 1y | €125k |
| of which > 1y | €51k |
| Working capital | €1.11M |
| Employees (FTE) | 2.0 |
| 2024 | |
|---|---|
| Current ratio | 9.92 |
| Quick ratio | 8.61 |
| Working capital ratio | 81.4% |
| Solvency | 83.6% |
| Debt / equity | 0.20 |
| Long-term debt ratio | 0.04 |
| Interest coverage | 45.01 |
| Gross margin | - |
| Net margin | - |
| ROA | 6.7% |
| ROE | 8.1% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.37M |
| Fixed assets | 21/28 | €130k |
| Tangible fixed assets | 22/27 | €130k |
| Current assets | 29/58 | €1.24M |
| Stocks & contracts in progress | 3 | €163k |
| Amounts receivable within one year | 40/41 | €13k |
| Investments | 50/53 | €732k |
| Cash & bank | 54/58 | €222k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.37M |
| Equity | 10/15 | €1.14M |
| Contributions / capital | 10/11 | €62k |
| Reserves | 13 | €192k |
| Accumulated profits (losses) | 14 | €888k |
| Amounts payable | 17/49 | €225k |
| Amounts payable after one year | 17 | €51k |
| Amounts payable within one year | 42/48 | €125k |
| Trade debts payable within one year | 44 | €87k |
| Income statement | ||
| Gross operating margin | 9900 | €280k |
| Operating result | 9901 | €119k |
| Financial income | 75 | €9k |
| Financial charges | 65 | €3k |
| Result before taxes | 9903 | €125k |
| Income taxes | 67/77 | €33k |
| Net result for the period | 9904 | €92k |
| Result to be appropriated | 9905 | €92k |
-
MEDISSARTLegal entityDirector· perm. rep.: CALONNE BénédicteState Gazette act 23438007 (28-11-2023)Current07-11-2023 → present
-
VAN QUICKELBERGHE XavierDirectorState Gazette act 23438007 (28-11-2023)Current07-11-2023 → present
2 events
- 07-11-2023 Appointed· Director
- 07-11-2023 Appointed· Managing director
| NACE primary | Detailhandel in farmaceutische producten(47730) |
| Legal form | Public limited company(014) |
| Incorporation | 15-11-1993 |
| Status | Active |
| Postal code | 7320 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 51009B0533/00P000 | Wallonia | 2,314 m² | 1 · 283 m² | 7.1 m · 1 fl. |
| 51009A0342/00D000 | Wallonia | 1,075 m² | 1 · 92 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
28-11-2023 3 directors appointed
- VAN QUICKELBERGHE Xavier, Bestuurder
- CALONNE Bénédicte, Bestuurder
- VAN QUICKELBERGHE Xavier, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "decharge_granted",
"role": null,
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale donne d\u00E9charge compl\u00E8te et enti\u00E8re aux administrateurs d\u00E9missionnaires pour l\u2019ex\u00E9cution de leur mandat.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "VAN QUICKELBERGHE Xavier",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": null,
"statutory": "niet_statutair",
"compensated": false,
"effective_date": "2023-11-07",
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de mettre fin \u00E0 la fonction des administrateurs actuels, mentionn\u00E9s ci-apr\u00E8s, et proc\u00E8de imm\u00E9diatement au renouvellement de leur nomination en qualit\u00E9 d\u2019administrateurs non statutaires pour une dur\u00E9e de six ann\u00E9es prenant cours ce jour",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "CALONNE B\u00E9n\u00E9dicte",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": null,
"name": "MEDISSART",
"address": null,
"country": null,
"legal_form": "SRL"
},
"statutory": "niet_statutair",
"compensated": false,
"effective_date": "2023-11-07",
"evidence_quote": "la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e MEDISSART, ici pr\u00E9sent et qui accepte par l\u2019interm\u00E9diaire de son administrateur, Madame CALONNE B\u00E9n\u00E9dicte.",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur_d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "VAN QUICKELBERGHE Xavier",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": "2023-11-07",
"evidence_quote": "les administrateurs d\u00E9cident \u00E0 l\u2019unanimit\u00E9 de confirmer et de renommer Monsieur VAN QUICKELBERGHE Xavier en qualit\u00E9 d\u2019administrateur d\u00E9l\u00E9gu\u00E9 et d\u2019administrateur d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re de la soci\u00E9t\u00E9 pour une dur\u00E9e de six ann\u00E9es prenant cours ce jour.",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": "Constant JONNIAUX",
"firm_city": null,
"firm_name": null,
"office_city": "Bernissart",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-11-28",
"filing_date": "2023-11-24",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2023-11-07",
"unanimous": null
},
{
"body": "algemene_vergadering",
"date": "2023-11-07",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2023-11-07",
"unanimous": null
},
{
"body": "algemene_vergadering",
"date": "2023-11-07",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0451.317.442",
"name_full": "PHARMACIE LECOMTE",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Constant JONNIAUX",
"org_rep_person_name": null,
"person_role_at_subject": "notaire"
},
"co_filed_documents": [
"exp\u00E9dition de l\u2019acte",
"statuts coordonn\u00E9s"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | PHARMACIE LECOMTE |